A staph infection is a type of bacterial infection that commonly occurs at sites of visible skin trauma (such as cuts and abrasions) and areas of the body covered by hair. One of the most common symptoms is a single red bump (or cluster of bumps); the affected site may also be swollen and painful. Treatment typically involves antibiotics, warm compresses, and draining of the infected area.
What Are Staph Infections?
A staph infection is caused by Staphylococcus bacteria. Staphylococci are gram-positive bacteria commonly found on the skin, in the nose, and within the mucous membranes of healthy people. Most of the time, they do not cause problems. However, the bacteria can sometimes get into the body and cause an infection.
Staphylococci are one of the most common causes of skin infections in the United States. They can also cause food poisoning, toxic shock syndrome, or serious infections within virtually any organ of the body. Some examples include infections within the lungs (pneumonia), bone (osteomyelitis), and soft tissue (cellulitis) (see Staph Infection Types).
There are several dozen strains of Staphylococcus bacteria. Only a couple are known to cause infections in humans. Staphylococcus aureus (S. aureus) is the most common cause of staph infections (see Staph Infection Causes).
Probably the most well-known Staphylococcus bacteria are methicillin-resistant Staphylococcus aureus, or MRSA for short. MRSA is a less common, but potentially more serious, strain of staph. It is resistant to antibiotics called beta-lactams. Beta-lactam antibiotics include methicillin and other more common antibiotics, such as oxacillin, penicillin, and amoxicillin (Amoxil®).
Over the past several decades, MRSA has gone from being a controllable cause of staph infections to a serious public health concern.
Locksley R. Staphylococcal infections. In: Harrison's Principles of Internal Medicine. 13th Edition. New York (NY): McGraw-Hill;1994:
Lowy FD. Staphylococcus aureus infections. N Engl J Med. 1998;339:520.
Klevens RM, Morrison MA, Nadle J, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA. 2007;298:1763.
Conterno LO, Wey SB, Castelo A. Risk factors for mortality in Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol. 1998;19:32-37.
Kuehnert MJ, Kruszon-Moran D, Hill HA, et al. Prevalence of Staphylococcus aureus nasal colonization in the United States, 2001-2002. J Infect Dis. 2006;193:172.
Coello R, Jiminez J, Garcia M, et al. Prospective study of infection, colonization and carriage of methicillin-resistant Staphylococcus aureus in an outbreak affecting 990 patients. Eur J Clin Microbiol Infect Dis. 1994;13:74.
Sanford MD, Widmer AF, Bale MJ, et al. Efficient detection and long-term persistence of the carriage of methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 1994;19:1123.
Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis. 2005 Nov 15;41(10):1373-406.
Gorwitz RJ. The role of ancillary antimicrobial therapy for treatment of uncomplicated skin infections in the era of community-associated methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 2007;44:785.
Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchemer AW, Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis. 2003;36(1):53-59.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click